Paul Eliezer Oberstein, Drew W. Rasco, Zev A. Wainberg, Thibaud Kossler, Antonia Digklia, Thomas J. George, Amit Mahipal, Anthony F. Shields, Sunnie S. Kim, Alexander I. Spira, Martin D. Berger, Vincent J. Picozzi, Andrés J. Muñoz Martín, Dirk Arnold, Víctor Moreno, Heinz-Josef Lenz, Petra Blum, Laetitia Devy-Dimanche, Hanjing Xie, Shubham Pant. "A phase 1b study to evaluate the safety, tolerability and preliminary efficacy of a heterologous prime boost vaccination (ATP150/ATP152/ATP162, VSV-GP154) and ezabenlimab (BI 754091) in patients with pancreatic ductal adenocarcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps794